Floor Talk with Judy Shaw
Cellares CEO on $380M collaboration with Bristol Myers Squibb and its impact
6m 18s
Cellares and Bristol Myers Squibb have entered a $380M collaboration to enhance the manufacturing of CAR T cell therapies.
Cellares Co-Founder & CEO Fabian Gerlinghaus talks about the terms of the agreement, its impact and future partnership plans on #NYSEFloorTalk with Judy Khan Shaw.
Up Next in 2024
-
Nuvemshop Co-Founder & CEO Santiago S...
About Nuvemshop:
Nuvemshop is a developer of an e-commerce platform designed for SMEs and entrepreneurs to sell products and services online. The company's platform offers product management, sales automation, integrations, and agreements to make shipments, enabling businesses to create and deve...
-
Nomad Global joins NYSE Floor Talk at...
About Nomad Global:
We are a Brazilian fintech that since 2020 has been operating with the aim of providing Brazilians with access to a global financial life, offering simplicity, security and savings in international transactions.
Through a single app, we offer different financial solutions, s...
-
Nowports joins NYSE Floor Talk at Lat...
About Nowports:
Developer of digital freight forwarder platform designed to handle freight transportation. The company's platform offers real-time tracking for freights, booking import or export cargo, and makes a fusion between technology and supply chain, enabling businesses to transport freig...
